EP3189044
CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.8.2015EP published:
1.8.2018EP application number:
15762875.1
EPO information:
European Patent Register
Max expiry date:
27.8.2035
Title:
CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
Timeline
Today
28.8.2015EP application
1.8.2018EP Publication
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
HUANG, PingAddress:
Indianapolis, Indiana, US
Name:
RIBE, Seth DietrichAddress:
Indianapolis, Indiana, US
Priority
Number:
PCT/CN2014/085925Date:
4.9.2014Country:
WO
Classification
Categories:
C07D 401/14, A61K 31/4439, A61P 13/10